Financial incentives to promote personalized medicine in Europe: an overview and guidance for implementation
Koleva-Kolarova R., Szilberhorn L., Zelei T., Vellekoop H., Nagy B., Huygens S., Versteegh M., Mölken MR-V., Wordsworth S., Tsiachristas A.
The implementation of adequate financing and reimbursement of personalized medicine (PM) in Europe is still turbulent. The views and experience of stakeholders about barriers in financing and reimbursing PM and potential solutions were elicited and supplemented with literature findings to draft a set of recommendations. Key recommendations to overcome the barriers for adequately financing and reimbursing PM in different healthcare systems in Europe included the provision of legal foundations and establishment of large pan-European databases, use of financial-based agreements and regulation of transparency of prices and reimbursement, and creating a business-friendly environment and attractive market for innovation. The recommendations could be used by health authorities for designing a sequence of policy steps to ensure the timely access to beneficial PM.